461 related articles for article (PubMed ID: 33252098)
1. A risk-stratified approach toward safely resuming OnabotulinumtoxinA injections based on dosing and ambulatory status in pediatric patients with cerebral palsy during the Coronavirus pandemic of 2019 (COVID-19).
McLaughlin MJ; Fisher MT; Vadivelu S; Ramsey J; Ratnasingam D; McGhee E; Hartman K
J Pediatr Rehabil Med; 2020; 13(3):273-279. PubMed ID: 33252098
[TBL] [Abstract][Full Text] [Related]
2. Effects of ultrasound-guided botulinum toxin type-A injections with a specific approach in spastic cerebral palsy.
Büyükavcı R; Büyükavcı MA
Acta Neurol Belg; 2018 Sep; 118(3):429-433. PubMed ID: 29694645
[TBL] [Abstract][Full Text] [Related]
3. Severity of cerebral palsy and likelihood of adverse events after botulinum toxin A injections.
Swinney CM; Bau K; Burton KLO; O'Flaherty SJ; Bear NL; Paget SP
Dev Med Child Neurol; 2018 May; 60(5):498-504. PubMed ID: 29451702
[TBL] [Abstract][Full Text] [Related]
4. Safety and Efficacy of a Propofol and Ketamine Based Procedural Sedation Protocol in Children with Cerebral Palsy Undergoing Botulinum Toxin A Injections.
Louer R; McKinney RC; Abu-Sultaneh S; Lutfi R; Abulebda K
PM R; 2019 Dec; 11(12):1320-1325. PubMed ID: 30761757
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal assessment of gait quality in children with bilateral cerebral palsy following repeated lower limb intramuscular Botulinum toxin-A injections.
Read FA; Boyd RN; Barber LA
Res Dev Disabil; 2017 Sep; 68():35-41. PubMed ID: 28735160
[TBL] [Abstract][Full Text] [Related]
6. Botulinum Toxin: Techniques Within Pediatric Physiatry.
Paulson A; Zigler CK; Houtrow A; Pruitt D
PM R; 2019 Jan; 11(1):38-44. PubMed ID: 29964211
[TBL] [Abstract][Full Text] [Related]
7. Combining strength training and botulinum neurotoxin intervention in children with cerebral palsy: the impact on muscle morphology and strength.
Williams SA; Elliott C; Valentine J; Gubbay A; Shipman P; Reid S
Disabil Rehabil; 2013 Apr; 35(7):596-605. PubMed ID: 22928803
[TBL] [Abstract][Full Text] [Related]
8. Systemic adverse events after botulinum neurotoxin A injections in children with cerebral palsy.
Paget SP; Swinney CM; Burton KLO; Bau K; O'Flaherty SJ
Dev Med Child Neurol; 2018 Nov; 60(11):1172-1177. PubMed ID: 30146721
[TBL] [Abstract][Full Text] [Related]
9. Medial gastrocnemius volume and echo-intensity after botulinum neurotoxin A interventions in children with spastic cerebral palsy.
Schless SH; Cenni F; Bar-On L; Hanssen B; Kalkman B; O'brien T; Aertbeliën E; Van Campenhout A; Molenaers G; Desloovere K
Dev Med Child Neurol; 2019 Jul; 61(7):783-790. PubMed ID: 30320442
[TBL] [Abstract][Full Text] [Related]
10. Motor endplate-targeted botulinum toxin injections of the gracilis muscle in children with cerebral palsy.
Van Campenhout A; Bar-On L; Desloovere K; Huenaerts C; Molenaers G
Dev Med Child Neurol; 2015 May; 57(5):476-83. PubMed ID: 25557985
[TBL] [Abstract][Full Text] [Related]
11. [Clinical experience of the repeated multilevel injections of the botulinum toxin type A (abobotulinum toxin A) in the spastic forms of cerebral palsy].
Klochkova OA; Kurenkov AL; Karimova HM; Namazova-Baranova LS; Memedyarov AM; Kuzenkova LM; Bursagova BI
Vestn Ross Akad Med Nauk; 2014; (9-10):57-63. PubMed ID: 25816644
[TBL] [Abstract][Full Text] [Related]
12. Consensus recommendations for botulinum toxin injections in the spasticity management of children with cerebral palsy during COVID-19 outbreak.
Yılmaz Yalçınkaya E; Karadağ Saygı E; Özyemişci Taşkıran Ö; Çapan N; Kutlay Ş; Sonel Tur B; El Ö; Ünlü Akyüz E; Tekin S; Ofluoğlu D; Zİnnuroğlu M; Akpınar P; Özekli Mısırlıoğlu T; Hüner B; Nur H; Çağlar S; Sezgin M; Tıkız C; Öneş K; İçağasıoğlu A; Aydın R
Turk J Med Sci; 2021 Apr; 51(2):385-392. PubMed ID: 33350298
[TBL] [Abstract][Full Text] [Related]
13. Intramuscular botulinum toxin prior to comprehensive rehabilitation has no added value for improving motor impairments, gait kinematics and goal attainment in walking children with spastic cerebral palsy.
Schasfoort F; Pangalila R; Sneekes EM; Catsman C; Becher J; Horemans H; Stam HJ; Dallmeijer AJ; Bussmann JBJ
J Rehabil Med; 2018 Aug; 50(8):732-742. PubMed ID: 30080235
[TBL] [Abstract][Full Text] [Related]
14. Effects of Botulinum Toxin A Injection on Ambulation Capacity in Patients with Cerebral Palsy.
Çağlar Okur S; Uğur M; Şenel K
Dev Neurorehabil; 2019 May; 22(4):288-291. PubMed ID: 30095354
[TBL] [Abstract][Full Text] [Related]
15. Treatment with botulinum toxin in children with cerebral palsy: a qualitative study of parents' experiences.
Lorin K; Forsberg A
Child Care Health Dev; 2016 Jul; 42(4):494-503. PubMed ID: 27198886
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the effects of botulinum toxin A injections when used to improve ease of care and comfort in children with cerebral palsy whom are non-ambulant: a double blind randomized controlled trial.
Thorley M; Donaghey S; Edwards P; Copeland L; Kentish M; McLennan K; Lindsley J; Gascoigne-Pees L; Sakzewski L; Boyd RN
BMC Pediatr; 2012 Aug; 12():120. PubMed ID: 22873758
[TBL] [Abstract][Full Text] [Related]
17. Development of an inventory of goals using the International Classification of Functioning, Disability and Health in a population of non-ambulatory children and adolescents with cerebral palsy treated with botulinum toxin A.
Nguyen L; Mesterman R; Gorter JW
BMC Pediatr; 2018 Jan; 18(1):1. PubMed ID: 29301539
[TBL] [Abstract][Full Text] [Related]
18. Botulinum toxin A for nonambulatory children with cerebral palsy: a double blind randomized controlled trial.
Copeland L; Edwards P; Thorley M; Donaghey S; Gascoigne-Pees L; Kentish M; Cert G; Lindsley J; McLennan K; Sakzewski L; Boyd RN
J Pediatr; 2014 Jul; 165(1):140-146.e4. PubMed ID: 24630348
[TBL] [Abstract][Full Text] [Related]
19. The key-muscle concept: a long-term low-dose injection strategy for botulinum toxin A treatment in cerebral palsy.
Placzek R; Salem KH; Meiss LA; Siebold D; Drescher W
Acta Orthop Belg; 2012 Feb; 78(1):111-6. PubMed ID: 22523937
[TBL] [Abstract][Full Text] [Related]
20. Should botulinum toxin A injections be repeated in children with cerebral palsy? A systematic review.
Kahraman A; Seyhan K; Değer Ü; Kutlutürk S; Mutlu A
Dev Med Child Neurol; 2016 Sep; 58(9):910-7. PubMed ID: 27103334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
